Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase Ib trial of multiple doses of temanogrel in volunteers

Trial Profile

Phase Ib trial of multiple doses of temanogrel in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Jul 2008

At a glance

  • Drugs Temanogrel (Primary)
  • Indications Thrombosis
  • Focus Adverse reactions
  • Sponsors Arena Pharmaceuticals
  • Most Recent Events

    • 09 Jul 2008 Positive results announced by Arena Pharmaceuticals.
    • 09 Jul 2008 Status changed from recruiting to completed.
    • 09 Jan 2008 Results are expected in mid-2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top